Loading organizations...
RYSE Asset Management is a London-based venture capital firm investing in early-stage HealthTech innovation. It backs companies developing tech-enabled solutions including digital diagnostics, therapeutics, medical devices, and data platforms. The firm improves healthcare access and impact by supporting founders tackling global challenges in mental health and health AI.
Founded in 2017, RYSE originated from a relationship with the NHS, investing in digital healthcare companies for global scaling. This insight into transforming health systems with technology fueled its inception. Key partners Shabir Chowdhary and Vivien de Tusch-Lec lead the firm with extensive healthcare and investment experience.
The firm supports visionary HealthTech startup founders, providing resources to accelerate ventures. RYSE collaborates with industry leaders like the NHS and Novartis, bridging ideas with real-world application. Its long-term vision is to reimagine healthcare and transform one billion lives globally via impactful innovations.
Key people at RYSE Asset Management.
RYSE Asset Management has 1 tracked investment across 1 company. The latest tracked deal is $2.0M Seed in Knokcare in November 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 3, 2020 | Knokcare | $2.0M Seed | Henry Wigan | Fascinating Folio OF Porto, Social Innovation Fund |
Key people at RYSE Asset Management.
